Cardiovascular Disease/ Myocardial Infarction

Contributing journals to this collection:
JAMA & Archives Journals

Citations 411-420 of 1831 total displayed.

Past content

Letters
Pioglitazone vs Glimepiride in the PERISCOPE Trial—Reply

Steven E. Nissen; Stephen J. Nicholls; Kathy Wolski
JAMA 2008; 300: 788. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes

Raffaele Marfella; Michelangela Barbieri; Giuseppe Paolisso
JAMA 2008; 300: 789. [Extract] [Full text] [PDF]  

Letters
Insulin Therapy and Lipid Overload in Type 2 Diabetes—Reply

Roger H. Unger
JAMA 2008; 300: 790. [Extract] [Full text] [PDF]  

Original Contributions
Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial

Marta Ebbing; Øyvind Bleie; Per Magne Ueland; Jan Erik Nordrehaug; Dennis W. Nilsen; Stein Emil Vollset; Helga Refsum; Eva Kristine Ringdal Pedersen; Ottar Nygård
JAMA 2008; 300: 795-804. [Abstract] [Full text] [PDF] [ JAMA Report Video ]  

Editorials
Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites

Lewis Landsberg
Arch Intern Med 2008; 168: 1607-1608. [Extract] [Full text] [PDF]  

Original Investigations
Identification and Characterization of Metabolically Benign Obesity in Humans

Norbert Stefan; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Kilian Rittig; Bernd Balletshofer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Arch Intern Med 2008; 168: 1609-1616. [Abstract] [Full text] [PDF]  

Original Investigations
The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004)

Rachel P. Wildman; Paul Muntner; Kristi Reynolds; Aileen P. McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R. Sowers
Arch Intern Med 2008; 168: 1617-1624. [Abstract] [Full text] [PDF]  

Original Investigations
Long-term Clinical Outcomes Following Coronary Stenting

Kevin J. Anstrom; David F. Kong; Linda K. Shaw; Robert M. Califf; Judith M. Kramer; Eric D. Peterson; Sunil V. Rao; David B. Matchar; Daniel B. Mark; Robert A. Harrington; Eric L. Eisenstein
Arch Intern Med 2008; 168: 1647-1655. [Abstract] [Full text] [PDF]  

Original Investigations
Cost-effectiveness of Proton Pump Inhibitor Cotherapy in Patients Taking Long-term, Low-Dose Aspirin for Secondary Cardiovascular Prevention

Sameer D. Saini; Philip Schoenfeld; A. Mark Fendrick; James Scheiman
Arch Intern Med 2008; 168: 1684-1690. [Abstract] [Full text] [PDF]  

Invited Commentary
Cost-effectiveness of Proton Pump Inhibitor Cotherapy in Patients Taking Long-term, Low-Dose Aspirin for Secondary Cardiovascular Prevention—Invited Commentary

Michael Pignone
Arch Intern Med 2008; 168: 1691. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184